- Home
- ATLCP vs CADL Comparison
ATLCP vs CADL Comparison
Compare ATLCP & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATLCP
- CADL
- Stock Information
- Founded
- ATLCP N/A
- CADL 1999
- Country
- ATLCP United States
- CADL United States
- Employees
- ATLCP 417
- CADL N/A
- Industry
- ATLCP Finance: Consumer Services
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- ATLCP Finance
- CADL Health Care
- Exchange
- ATLCP Nasdaq
- CADL Nasdaq
- Market Cap
- ATLCP N/A
- CADL 234.8M
- IPO Year
- ATLCP N/A
- CADL 2021
- Fundamental
- Price
- ATLCP $22.05
- CADL $4.92
- Analyst Decision
- ATLCP
- CADL Strong Buy
- Analyst Count
- ATLCP 0
- CADL 5
- Target Price
- ATLCP N/A
- CADL $21.40
- AVG Volume (30 Days)
- ATLCP N/A
- CADL 935.0K
- Earning Date
- ATLCP N/A
- CADL 08-12-2025
- Dividend Yield
- ATLCP N/A
- CADL N/A
- EPS Growth
- ATLCP N/A
- CADL N/A
- EPS
- ATLCP N/A
- CADL N/A
- Revenue
- ATLCP N/A
- CADL N/A
- Revenue This Year
- ATLCP N/A
- CADL N/A
- Revenue Next Year
- ATLCP N/A
- CADL N/A
- P/E Ratio
- ATLCP N/A
- CADL N/A
- Revenue Growth
- ATLCP N/A
- CADL N/A
- 52 Week Low
- ATLCP N/A
- CADL $3.79
- 52 Week High
- ATLCP N/A
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- ATLCP 31.73
- CADL 45.17
- Support Level
- ATLCP $22.01
- CADL $4.48
- Resistance Level
- ATLCP $22.18
- CADL $4.97
- Average True Range (ATR)
- ATLCP 0.12
- CADL 0.35
- MACD
- ATLCP -0.01
- CADL -0.06
- Stochastic Oscillator
- ATLCP 10.50
- CADL 32.05
About ATLCP Atlanticus Holdings Corporation 7.625% Series B Cumulative Perpetual Preferred Stock no par value per share
Atlanticus Holdings Corp invests in the financial services industry. It provides various credit and related financial services and products to or associated with the financially underserved consumer credit market. The operating business segments are the Credit as a Service (CaaS) and the Auto Finance segment. It generates maximum revenue from the Credit as a Service segment.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.